{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Meningococcal+Polysaccharide+%28Serogroups+A%2C+C%2C+Y%2C+and+W%29+Tetanus+Toxoid+Conjugate", "query": { "intervention": "Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 14, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Meningococcal+Polysaccharide+%28Serogroups+A%2C+C%2C+Y%2C+and+W%29+Tetanus+Toxoid+Conjugate&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-09T12:44:40.934Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02752906", "title": "Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningitis", "Meningococcal Meningitis", "Meningococcal Infections" ], "interventions": [ { "name": "Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "15 Years", "maximum_age": null, "sex": "ALL", "summary": "15 Years and older" }, "enrollment_count": 810, "start_date": "2016-04-15", "completion_date": "2016-12-19", "has_results": true, "last_update_posted_date": "2022-04-05", "last_synced_at": "2026-10-09T12:44:40.934Z", "location_count": 29, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Mesa, Arizona + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Downey", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02752906" }, { "nct_id": "NCT03537508", "title": "Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Healthy Volunteers (Meningococcal Infection)" ], "interventions": [ { "name": "MenACYW conjugate vaccine", "type": "BIOLOGICAL" }, { "name": "MenACYW-135 conjugate vaccine", "type": "BIOLOGICAL" }, { "name": "DTaP-IPV//Hib vaccine", "type": "BIOLOGICAL" }, { "name": "Pneumococcal 13-valent conjugate vaccine", "type": "BIOLOGICAL" }, { "name": "Pentavalent rotavirus vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis B vaccine", "type": "BIOLOGICAL" }, { "name": "Measles, mumps, rubella (MMR) vaccine", "type": "BIOLOGICAL" }, { "name": "Varicella vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis A vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "89 Days", "sex": "ALL", "summary": "42 Days to 89 Days" }, "enrollment_count": 2627, "start_date": "2018-04-25", "completion_date": "2023-09-22", "has_results": true, "last_update_posted_date": "2024-10-15", "last_synced_at": "2026-10-09T12:44:40.934Z", "location_count": 65, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Phoenix, Arizona + 54 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03537508" }, { "nct_id": "NCT04825223", "title": "Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Meningococcal Immunisation", "Healthy Volunteers" ], "interventions": [ { "name": "Multicomponent Meningococcal B Vaccine", "type": "DRUG" }, { "name": "Meningococcal Group B Vaccine MenB", "type": "DRUG" }, { "name": "Meningococcal Group B Vaccine (recombinant deoxyribonucleic acid [rDNA], component, adsorbed)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine MenACYW conjugate vaccine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "50 Years", "sex": "ALL", "summary": "42 Days to 50 Years" }, "enrollment_count": 576, "start_date": "2021-03-29", "completion_date": "2022-07-22", "has_results": false, "last_update_posted_date": "2025-10-10", "last_synced_at": "2026-10-09T12:44:40.934Z", "location_count": 8, "location_summary": "Guntersville, Alabama • San Diego, California • Tampa, Florida + 5 more", "locations": [ { "city": "Guntersville", "state": "Alabama" }, { "city": "San Diego", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "El Dorado", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04825223" }, { "nct_id": "NCT03077438", "title": "Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningitis", "Meningococcal Meningitis", "Meningococcal Infections" ], "interventions": [ { "name": "Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate", "type": "BIOLOGICAL" }, { "name": "Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": "9 Years", "sex": "ALL", "summary": "2 Years to 9 Years" }, "enrollment_count": 1000, "start_date": "2017-02-17", "completion_date": "2017-10-10", "has_results": true, "last_update_posted_date": "2022-03-28", "last_synced_at": "2026-10-09T12:44:40.934Z", "location_count": 35, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Tucson, Arizona + 31 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03077438" }, { "nct_id": "NCT07197762", "title": "MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young Adults", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Neisseria Meningitidis" ], "interventions": [ { "name": "Trumenba", "type": "BIOLOGICAL" }, { "name": "PENBRAYA", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "18 Years to 25 Years" }, "enrollment_count": 125, "start_date": "2025-11-04", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2025-12-22", "last_synced_at": "2026-10-09T12:44:40.934Z", "location_count": 2, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07197762" }, { "nct_id": "NCT04843111", "title": "Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® During Pregnancy, in United States (US)", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Meningococcal Infection" ], "interventions": [ { "name": "Meningococcal polysaccharide (serogroups A, C, Y, and W) tetanus toxoid conjugate vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 50, "start_date": "2021-03-05", "completion_date": "2028-05-18", "has_results": false, "last_update_posted_date": "2025-12-01", "last_synced_at": "2026-10-09T12:44:40.934Z", "location_count": 1, "location_summary": "Swiftwater, Pennsylvania", "locations": [ { "city": "Swiftwater", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04843111" }, { "nct_id": "NCT02810340", "title": "Study of Meninigococcal Conjugate Vaccine Containing Serogroups A,C,Y,W and X (MCV5) in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Meningococcal Vaccines" ], "interventions": [ { "name": "Adjuvanted MCV-5", "type": "BIOLOGICAL" }, { "name": "Non-Adjuvanted MCV-5", "type": "BIOLOGICAL" }, { "name": "Menactra®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "PATH", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 60, "start_date": "2016-08-01", "completion_date": "2017-10-13", "has_results": true, "last_update_posted_date": "2021-06-09", "last_synced_at": "2026-10-09T12:44:40.934Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02810340" }, { "nct_id": "NCT02842853", "title": "Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningitis", "Meningococcal Meningitis", "Meningococcal Infections" ], "interventions": [ { "name": "Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "10 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "10 Years to 55 Years" }, "enrollment_count": 3344, "start_date": "2016-07-15", "completion_date": "2017-02-28", "has_results": true, "last_update_posted_date": "2022-04-05", "last_synced_at": "2026-10-09T12:44:40.934Z", "location_count": 89, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Mobile, Alabama + 72 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02842853" }, { "nct_id": "NCT03673462", "title": "Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Healthy Volunteers (Meningococcal Infection)" ], "interventions": [ { "name": "Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid Conjugate vaccine (MenACYW Conjugate vaccine)", "type": "BIOLOGICAL" }, { "name": "Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine (MENVEO®)", "type": "BIOLOGICAL" }, { "name": "Diphtheria, Tetanus, Acellular Pertussis, Poliovirus and Haemophilus b Vaccine", "type": "BIOLOGICAL" }, { "name": "Pneumococcal 13-valent Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Rotavirus Vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis B Vaccine", "type": "BIOLOGICAL" }, { "name": "Measles, Mumps, and Rubella Virus Vaccine", "type": "BIOLOGICAL" }, { "name": "Varicella Virus Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "89 Days", "sex": "ALL", "summary": "42 Days to 89 Days" }, "enrollment_count": 2797, "start_date": "2018-09-17", "completion_date": "2023-03-16", "has_results": true, "last_update_posted_date": "2023-12-14", "last_synced_at": "2026-10-09T12:44:40.934Z", "location_count": 67, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Phoenix, Arizona + 56 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Hot Springs", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03673462" }, { "nct_id": "NCT02842866", "title": "Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningitis", "Meningococcal Meningitis", "Meningococcal Infections" ], "interventions": [ { "name": "Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Meningococcal Polysaccharide Vaccine, Groups A, C, Y, and W-135 Combined", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "56 Years", "maximum_age": null, "sex": "ALL", "summary": "56 Years and older" }, "enrollment_count": 907, "start_date": "2016-07-15", "completion_date": "2017-02-13", "has_results": true, "last_update_posted_date": "2022-04-05", "last_synced_at": "2026-10-09T12:44:40.934Z", "location_count": 35, "location_summary": "Chandler, Arizona • Anaheim, California • San Diego, California + 28 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Waterbury", "state": "Connecticut" }, { "city": "Clearwater", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02842866" } ] }